vs
Side-by-side financial comparison of GLADSTONE COMMERCIAL CORP (GOOD) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $43.5M, roughly 1.7× GLADSTONE COMMERCIAL CORP). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 16.3%). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 10.3%).
Gladstone Commercial Corp is a publicly traded US real estate investment trust focused on acquiring, owning, and operating diversified industrial and commercial properties. It offers long-term net lease agreements to tenants across manufacturing, logistics, healthcare and professional services sectors, mainly serving small to mid-sized business clients.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
GOOD vs PBYI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $43.5M | $75.5M |
| Net Profit | $5.4M | — |
| Gross Margin | — | 69.3% |
| Operating Margin | — | 22.7% |
| Net Margin | 12.4% | — |
| Revenue YoY | 16.3% | 27.7% |
| Net Profit YoY | -25.1% | — |
| EPS (diluted) | $0.05 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $43.5M | $75.5M | ||
| Q3 25 | $40.8M | $54.5M | ||
| Q2 25 | $39.5M | $52.4M | ||
| Q1 25 | $37.5M | $46.0M | ||
| Q4 24 | $37.4M | $59.1M | ||
| Q3 24 | $39.2M | $80.5M | ||
| Q2 24 | $37.1M | $47.1M | ||
| Q1 24 | $35.7M | $43.8M |
| Q4 25 | $5.4M | — | ||
| Q3 25 | $4.1M | $8.8M | ||
| Q2 25 | $4.6M | $5.9M | ||
| Q1 25 | $5.1M | $3.0M | ||
| Q4 24 | $7.2M | — | ||
| Q3 24 | $11.7M | $20.3M | ||
| Q2 24 | $1.6M | $-4.5M | ||
| Q1 24 | $3.5M | $-4.8M |
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
| Q4 25 | — | 22.7% | ||
| Q3 25 | — | 17.6% | ||
| Q2 25 | — | 12.7% | ||
| Q1 25 | — | 8.7% | ||
| Q4 24 | — | 22.6% | ||
| Q3 24 | — | 27.4% | ||
| Q2 24 | — | -4.6% | ||
| Q1 24 | — | -5.3% |
| Q4 25 | 12.4% | — | ||
| Q3 25 | 10.1% | 16.2% | ||
| Q2 25 | 11.7% | 11.2% | ||
| Q1 25 | 13.7% | 6.5% | ||
| Q4 24 | 19.2% | — | ||
| Q3 24 | 29.8% | 25.2% | ||
| Q2 24 | 4.3% | -9.6% | ||
| Q1 24 | 9.9% | -11.0% |
| Q4 25 | $0.05 | $0.26 | ||
| Q3 25 | $0.02 | $0.17 | ||
| Q2 25 | $0.03 | $0.12 | ||
| Q1 25 | $0.04 | $0.06 | ||
| Q4 24 | $0.10 | $0.40 | ||
| Q3 24 | $0.20 | $0.41 | ||
| Q2 24 | $-0.04 | $-0.09 | ||
| Q1 24 | $0.01 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $10.8M | $97.5M |
| Total DebtLower is stronger | $843.5M | $22.7M |
| Stockholders' EquityBook value | $171.8M | $130.3M |
| Total Assets | $1.2B | $216.3M |
| Debt / EquityLower = less leverage | 4.91× | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $10.8M | $97.5M | ||
| Q3 25 | $18.4M | $94.4M | ||
| Q2 25 | $11.7M | $96.0M | ||
| Q1 25 | $10.4M | $93.2M | ||
| Q4 24 | $11.0M | $101.0M | ||
| Q3 24 | $10.5M | $96.7M | ||
| Q2 24 | $10.4M | $96.8M | ||
| Q1 24 | $10.5M | $107.2M |
| Q4 25 | $843.5M | $22.7M | ||
| Q3 25 | $843.3M | $34.0M | ||
| Q2 25 | $794.4M | $45.3M | ||
| Q1 25 | $740.7M | $56.7M | ||
| Q4 24 | $693.4M | $68.0M | ||
| Q3 24 | $692.6M | $79.3M | ||
| Q2 24 | $722.5M | $90.7M | ||
| Q1 24 | $719.4M | $102.0M |
| Q4 25 | $171.8M | $130.3M | ||
| Q3 25 | $184.8M | $115.3M | ||
| Q2 25 | $177.2M | $104.7M | ||
| Q1 25 | $183.2M | $97.1M | ||
| Q4 24 | $171.2M | $92.1M | ||
| Q3 24 | $168.9M | $71.1M | ||
| Q2 24 | $145.7M | $48.5M | ||
| Q1 24 | $147.3M | $51.0M |
| Q4 25 | $1.2B | $216.3M | ||
| Q3 25 | $1.3B | $202.9M | ||
| Q2 25 | $1.2B | $194.9M | ||
| Q1 25 | $1.2B | $196.2M | ||
| Q4 24 | $1.1B | $213.3M | ||
| Q3 24 | $1.1B | $220.7M | ||
| Q2 24 | $1.1B | $205.0M | ||
| Q1 24 | $1.1B | $214.1M |
| Q4 25 | 4.91× | 0.17× | ||
| Q3 25 | 4.56× | 0.30× | ||
| Q2 25 | 4.48× | 0.43× | ||
| Q1 25 | 4.04× | 0.58× | ||
| Q4 24 | 4.05× | 0.74× | ||
| Q3 24 | 4.10× | 1.12× | ||
| Q2 24 | 4.96× | 1.87× | ||
| Q1 24 | 4.88× | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $88.2M | $14.4M |
| Free Cash FlowOCF − Capex | — | $14.4M |
| FCF MarginFCF / Revenue | — | 19.1% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | 16.38× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $88.2M | $14.4M | ||
| Q3 25 | $18.9M | $9.7M | ||
| Q2 25 | $35.8M | $14.1M | ||
| Q1 25 | $17.7M | $3.6M | ||
| Q4 24 | $57.0M | $15.6M | ||
| Q3 24 | $5.5M | $11.0M | ||
| Q2 24 | $13.6M | $1.0M | ||
| Q1 24 | $15.0M | $11.2M |
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M | ||
| Q1 24 | — | — |
| Q4 25 | — | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | — | 2.1% | ||
| Q1 24 | — | — |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.0% |
| Q4 25 | 16.38× | — | ||
| Q3 25 | 4.57× | 1.10× | ||
| Q2 25 | 7.74× | 2.41× | ||
| Q1 25 | 3.44× | 1.21× | ||
| Q4 24 | 7.93× | — | ||
| Q3 24 | 0.47× | 0.54× | ||
| Q2 24 | 8.44× | — | ||
| Q1 24 | 4.26× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
